What drugs does LIB THERAPEUTICS, INC. make?

LIB THERAPEUTICS, INC. has 1 FDA-approved drugs.

What therapeutic areas does LIB THERAPEUTICS, INC. focus on?

LIB THERAPEUTICS, INC. focuses primarily on Immunology and Cardiovascular and 1 other therapeutic areas.

← Back

Data updated: Mar 29, 2026

LIB THERAPEUTICS, INC.

ImmunologyCardiovascularDermatology

Biotech

LIB THERAPEUTICS, INC. is a biotechnology company focused on Immunology, Cardiovascular, Dermatology.

2025

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

LEROCHOL 2025-12-12

Type 1 - New Molecular Entity

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 76%

0 drugs Phase 3: 5 Phase 2: 3

Cardiovascular 18%

1 drugs

Dermatology 6%

0 drugs Phase 2: 1

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

BAUSCH specialty

Dermatology, Immunology, Cardiovascular

COSETTE other

Cardiovascular, Dermatology, Immunology

BAUSCH AND LOMB specialty

Cardiovascular, Dermatology, Immunology

Pfizer big-pharma

Dermatology, Immunology

PAI HOLDINGS PHARM big-pharma

Dermatology, Cardiovascular, Immunology

LIB THERAPEUTICS, INC.

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info

LIB THERAPEUTICS, INC.

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info